Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TOCOSOL Paclitaxel vs Taxol in Metastatic Breast Cancer
NCT00251095Phase 3Terminated
- Sponsor
- Achieve Life Sciences
- Start
- Sep 2005
- Primary completion
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of paclitaxel in breast cancer (2 arms), sponsored by Achieve Life Sciences. Primary endpoints: Objective Response Rate and Toxicities. Started Sep 2005; status: terminated.
02
Drugs
paclitaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00251095.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00251095.